Blood Journals Portfolio/ LinkedIn
Aug 24, 2025, 07:47
Enhao Li on Key Immune Differences Between HA and HB Patients with Inhibitors: B Cells Versus T Cells Dominance
Blood Journals Portfolio shared on X:
“B cells dominate in patients with HA with inhibitors, whereas T cells are relatively more active in those with HB with inhibitors.”
Read the full article here.
Article: Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX
Authors: Enhao Li, Zekun Li, Jinzeng Wang, Haoyang Wu, Yilun Xue, Can Lou, Zhenping Chen, Feng Liu, Wenman Wu, Qiulan Ding, Runhui Wu, Xuefeng Wang, Jing Dai

Keep up with advances in hematology research through Hemostasis Today.
B Cells
Blood Research
Can Lou
Enhao Li
Feng Liu
FIX
FVIII
Haoyang Wu
Health
Hematology
Hemophilia
Hemophilia A
Hemophilia B
Hemostasis
Hemostasis Today
Immune Response
inhibitors
Jing Dai
Jinzeng Wang
Medical Research
Medicine
PBMC
Qiulan Ding
Runhui Wu
Single-Cell Sequencing
T Cells
Wenman Wu
Xuefeng Wang
Yilun Xue
Zekun Li
Zhenping Chen
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community